An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

NCT03896295 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class

Stopped Study was originally halted due to the COVID-19 pandemic. The study was later terminated prematurely as the participants will have the option to enter into an open-label extension portion of a planned future study. It was not due to safety concerns.

Conditions

Interventions

Sponsor

Momenta Pharmaceuticals, Inc.